PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
6.23%
Net income growth at 50-75% of VUZI's 11.25%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
17.39%
D&A growth well above VUZI's 22.92%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
71.43%
Deferred tax of 71.43% while VUZI is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
3.17%
SBC growth while VUZI is negative at -72.80%. John Neff would see competitor possibly controlling share issuance more tightly.
181.65%
Slight usage while VUZI is negative at -19.64%. John Neff would note competitor possibly capturing more free cash unless expansions are needed here.
-169.55%
Both yoy AR lines negative, with VUZI at -73.35%. Martin Whitman would suspect an overall sector lean approach or softer demand.
-145.26%
Negative yoy inventory while VUZI is 80.56%. Joel Greenblatt would see a near-term cash advantage if top-line doesn't suffer.
184.82%
A yoy AP increase while VUZI is negative at -192.98%. John Neff would see competitor possibly improving relationships or liquidity more rapidly.
4.46%
Lower 'other working capital' growth vs. VUZI's 352.14%. David Dodd would see fewer unexpected short-term demands on cash.
No Data
No Data available this quarter, please select a different quarter.
67.17%
Some CFO growth while VUZI is negative at -38.64%. John Neff would note a short-term liquidity lead over the competitor.
-40.29%
Both yoy lines negative, with VUZI at -18.60%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
No Data
No Data available this quarter, please select a different quarter.
7.73%
Purchases growth of 7.73% while VUZI is zero at 0.00%. Bruce Berkowitz sees a mild difference in portfolio building that might matter for returns.
-23.53%
We reduce yoy sales while VUZI is 0.00%. Joel Greenblatt sees competitor possibly capitalizing on market peaks or forced to raise cash while we hold tight.
1150.00%
Growth well above VUZI's 6.90%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
-46.52%
Both yoy lines negative, with VUZI at -13.57%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
57.33%
Lower share issuance yoy vs. VUZI's 124.06%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
No Data
No Data available this quarter, please select a different quarter.